PONV unplugged

Seminars in Anesthesia, Perioperative Medicine and Pain

Volumn 23, Issue 3, 2004, Pages 203-220

  Pergolizzi Jr , Joseph V ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Naples Anesthesia and Pain Associates   (United States)

^c Intl Pain Res and Treatm Found   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIEMETIC AGENT; ATROPINE; BENZAMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPROPANE; DESFLURANE; DEXAMETHASONE; DOLASETRON MESILATE; DROPERIDOL; ENFLURANE; ETHER; ETOMIDATE; GRANISETRON; HALOTHANE; ISOFLURANE; KETAMINE; METOCLOPRAMIDE; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; OPIATE; PHENOTHIAZINE; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; SEROTONIN ANTAGONIST; SEVOFLURANE; TROPISETRON; UNINDEXED DRUG;

ABDOMINAL PAIN; ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANESTHESIA; CLINICAL TRIAL; CONSENSUS; CONSTIPATION; DIZZINESS; DROWSINESS; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SURGERY; HEADACHE; HUMAN; HYPOTENSION; LASSITUDE; MORBIDITY; MORTALITY; NAUSEA; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL ANATOMY; SURGICAL TECHNIQUE; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 5144235135     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sane.2004.02.002     Document Type: Article

References (86)

1. Committee on Quality of Healthcare in America. Crossing the quality chasm a new health system for the 21st century. 2001;Institute of Medicine, Washington DC
2. Andrews E. Relative dangers of Anesthesia by chloroform and ether statistics of 209,893 cases. Chicago Medical Examiner. 11:1870;257-266
3. Pergolizzi J. Special report current issues in managing PONV. 2003;. Anesthesiology News, April
4. Orkin L.R. Abstract. International Anesthesia Research Society 66th Congress. San Francisco, California, March 13-17 Anesth Analg. 74:1992;S225
5. Eberhart L.H.J., Morin M., Wulf H., et al. Patient preferences for immediate postoperative recovery. Br J Anaesth. 89:2002;760-761
6. Gan T.J., Sloan F., Dear Gde L., et al. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg. 92:2001;393-400
7. Hill R.P., Lubarsky D.A., Phillips-Bute B., et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 92:2000;958-967
8. Macario A., Weinger M., Carney S., et al. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 89:1999;652-658
9. Carroll N.V., Miederhoff P., Cox F.M., et al. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg. 80:1995;903-909
10. Leslie J. Lecture on PONV in same day surgery. 2003;. Boston, April
11. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997 results of a follow-up national survey. JAMA. 280:1998;1569-1575
12. Lee A., Done M.L. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting a meta-analysis. Anesth Analg. 88:1999;1362-1369
13. Zarate E. The use of transcutaneous acupoint electrical stimulation for preventing nausea and vomiting after laparoscopic surgery. Anesth Analg. 92:2001;629-635
14. Anderson L., Gross J. Deep breathing alone may relieve nausea. 2002;Anesthesiology News. 20-21, Jan
15. Sanz L. Lecture clinical issues for OB/GYNs in the management of nausea and vomiting, May. 2003;Academy for Healthcare Education
16. Watcha M.F., White P.F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 77:1992;162-184
17. Natof, et al. Wetchler. Anesthesia for ambulatory surgery. 2nd edition :1991;. Chapter 8
18. Cameron D., Gan T.J. Management of PONV in ambulatory surgery. Anesth Clin N Am. 21:2003;347-365
19. Marcus J.R., Few J.W., Chao J.D., et al. The prevention of emesis in plastic surgery A randomized, prospective study. Plastic Reconstr Surg. 109:2002;2487-2494
20. Beattie W.S., Lindblad T., Buckley D.N., et al. The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth. 38:1991;298-302
21. Bellville J.W. Postanesthetic nausea and vomiting. Anesthesiology. 22:1961;773-780
22. Gan T.J. Risk Assessment for the management of postoperative nausea and vomiting. Clin Res. 11:2001;32-37
23. Bibby P.F. Pain as a major cause of postoperative nausea. Br J Nurs. 10:2001;775-780
24. Kovac A.L. Pain as a major cause of postoperative nausea. Drugs. 59:2000;213-243
25. Anderson R., Kroh K. Pain as a major cause of postoperative nausea. Can Anesth Soc J. 23:1976;366-369
26. Stadler M., Bardiau F., Seidel L., et al. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology. 98:2003;46-52
27. Perkins F.M., Kehlet H. Chronic pain as an outcome of surgery a review of predictive factors. Anesthesiology. 93:2000;1123-1133
28. Nuovo J., Melnikow J., Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA. 287:2002;2813-2814
29. Andrews P.L.R. Physiology of nausea and vomiting. Br J Anaesth. 69:(Suppl 1):1992;2S-19S
30. Tramer M.R. A rational approach to the control of postoperative nausea and vomiting evidence from systematic reviews. Acta Anaesth Scand. 45:2001;4-19
31. FDA Press Release. FDA strengthens warnings for droperidol, December 5. 2001
32. Scuderi P.E., James R.L., Harris L., et al. Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. [comment]. Anesthesiology. 90:1999;360-371
33. Sinclair D.R., Chung F., Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology. 91:1999;109-118
34. Apfel C.C., Greim C.A., Haubitz I., et al. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand. 42:1998;495-501
35. Apfel C.C., Greim C.A., Haubitz I., et al. The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol Scand. 42:1998;502-509
36. Apfel C.C., Laara E., Koivuranta M., et al. A simplified risk score for predicting postoperative nausea and vomiting conclusions from cross-validations between two centers. Anesthesiology. 91:1999;693-700
37. Koivuranta M., Laara E., Snare L. A survey of postoperative nausea and vomiting. Anaesthesia. 52:1997;443-449
38. Junger A., Hartmann B., Benson M., et al. The use of an anesthesia information management system for prediction of antiemetic rescue treatment at the postanesthesia care unit. Anesth Analg. 92:2001;1203-1209
39. Gan T.J., Meyer T., Apfel C.C., et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 97:2003;62-71
40. Apfel C.C., Kranke P., Greim C.A., et al. What can be expected from risk scores for predicting postoperative nausea and vomiting? Br J Anaesth. 86:2001;822-827
41. Thomas R., Jones N.A., Strike P. The value of risks scores for predicting postoperative nausea and vomiting when used to compare patient group in a randomised controlled trial. Anaesthesia. 57:2002;1119-1128
42. Golembiewski J., Pergolizzi J. Postoperative Nausea and Vomiting A Guide to Risk Assessment and Therapy. Pharmacy Practice News Special Report. 2003;1-12. April
43. Claybon L, Guzzi L, Pergolizzi J: Presentation 2002 NYSA- PGA Symposium on Effective Management Strategies for PONV
44. Barsan W.G., et al. Rosenp,, et al. Emergency medicine concepts and clinical practice. 4th edition :1998;1960-1964 Mosby-Year Book Inc, St. Louis, MO
45. Burkhart D.M. Management of acute gastroenteritis in children. Am Fam Physicians. 60:1999;2555-2566
46. Hornby P.J. Central neurocircuitry associated with emesis. Am J Med. 111:2001;106S-112S
47. 3 receptors in rodents. J Neurochem. 75:2000;240-247
48. van Wijngaarden I., Tulp M.T., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur J Pharmacol. 188:1990;301-312
49. Miller A.D. Central mechanisms of vomiting. Digest Dis Sci. 44:1999;39S-43S
50. Tortorice P.V., O'Connell B.M. Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy. 10:1990;129-145
51. Pergolizzi J., et al. Advances in the ambulatory management of nausea and vomiting. EM Physicians Lecture and CME Series. 2002
52. Pergolizzi J.P., Neobyl J., Goodwin T.M. OB/GYN Special Edition, Special report clinical issues for OB/GYNs in the management of nausea and vomiting. 2003;Academy for Healthcare Education CME
53. American Society of Health-System Pharmacists. Drug shortages resource center. Antiemetics. www.ashp.org/shortage/antiemetic.cfm?cfid= 1494847&CFToken=83088327#ref (accessed January 7, 2003)
54. Habib A.S., Gan T.J. Special Report: anesthesiology news: postoperative nausea and vomiting. Prev Manage 110. 2003
55. Prephenazine product information. Mosby's Drug Consult. Available by subscription at www.mosbysdrugconsult.com (accessed 10/22/02)
56. Lui K., Hsu C.C., Chia Y.Y. Effect of dexamethasone on postoperative emesis and pain. Br J Anaesth. 80:1998;85-86
57. Harris A.L. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet. 1:1982;714-716
58. Macario A., Chung A., Weinger M.B. Variation in practice patterns of anesthesiologists in California for prophylaxis of postoperative nausea and vomiting. J Clin Anesth. 13:2001;353-360
59. Prescribing Information for ZOFRAN Injection. 2002;GlaxoSmithKline. April
60. Prescribing Information for Anzemet® (dolasetron) Injection. 2003;Aventis Pharmaceuticals Inc. February
61. Prescribing Information for Kytril® (granisetron) Injection. 2002;Roche Pharmaceuticals. August
62. Loewen P.S., Marra C.A., Zed P.J. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anaesth. 47:2000;1008-1018
63. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm. 56:1999;729-764. Anonymous
64. Goodman N.W. Trials of postoperative antiemetics need three arms. Br Med J. 318:1999;942
65. 2003 Drug Topics Red Book. Cardinale. 5th edition :2003;Medical Economics Co. Inc, Montvale
66. Korttila K., Clergue F., Leeser J., et al. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting a multicenter, double-blind, placebo-controlled study. Acta Anaesthesiol Scand. 41:1997;914-922
67. D'Angelo RD,, et al. PGA NYSSA 2002 Abstract
68. Singh S., Sharma D.R., Chaudhary A. Evaluation of prochlorperazine buccal tablets (Bukatel) and metoclopramide oral tablets in the treatment of acute emesis. J Indian Med Assoc. 97:1999;346-347
69. Ormrod D., Goa K.L. Intranasal metoclopramide. Drugs. 58:1999;315-322
70. Gan T.J., Franiak R., Reeves J. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg. 94:2002;1199-1200
71. Gesztesi Z., Scuderi P.E., White P.F., et al. Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology. 93:2000;931-937
72. Yamakuni H., Sawai H., Maeda Y., et al. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs. J Pharmacol Exp Ther. 292:2000;1002-1007
73. Diemunsch P., Grelot L. Potential of substance P antagonists as antiemetics. Drugs. 60:2000;533-546
74. Prescribing information for Emend® (Aprepitant). 2003;Oral Merck & CO Inc. March
75. Page A.J., Martin C.M., Blackshaw L.A. Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol. 87:2002;2095-2103
76. Purhonen S., Turunen M., Ruohoaho U., et al. Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesth Analg. 96:2003;91-96
77. Monti S., Pokorny M.E. Preop fluid bolus reduces risk of post op nausea and vomiting a pilot study. Internet Journal of Advanced Nursing Practice 4. 2000
78. Moretti E.W., Robertson K.M., El-Moalem H., et al. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg. 96:2003;611-617
79. Di Florio T., Goucke C.R. The effect of midazolam on persistent postoperative nausea and vomiting. Anaesth Intensive Care. 27:1999;38-40
80. Arrow K.J. Reflections on the reflections. J Health Politics Policy Law. 26:2001;851-883
81. Wilson A.E. De-mystifying pharmacoeconomics. Drug Benefit Trends. 11:1999;56-67
82. Practice Guidelines for Postanesthetic Care Anesthesiology. March 2002 (www.anesthesiology.org)
83. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm. 56:1999;729-764
84. Leslie J.B. How can we best prevent or treat postoperative nausea and vomiting? Curr Opin Anaesthesiol. 14:2001;623-627
85. Adapted from Blum R: TDS: A phoenix from the ashes? Clin Res. 9:2001;32-35
86. Claybon L,, et al. Unpublished data presented at PGA NYSSA 2002